You are here: Industry Insights > patients

News List

Executive Moves: AbbVie contractpharma
December 18, 2018
AbbVie has made changes to its Executive Leadership Team as part of an effort to streamline its organizational structure and support its growth strategy. The following will report to AbbVie chairman and chief executive officer Richard A. Gonzalez.
Janssen, OHCA Enter LAIs Contract contractpharma
December 17, 2018
Janssen Pharmaceuticals, Inc. has entered a results-based contract for long-acting injectable schizophrenia medicines (LAIs) with the Oklahoma Health Care Authority (OHCA), which manages Oklahoma's Medicaid plan, SoonerCare.
AMAG Acquires Perosphere contractpharma
December 17, 2018
AMAG Pharmaceuticals has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc.
NW Bio Announces Deal Worth $47M contractpharma
December 12, 2018
Northwest Biotherapeutics ("NW Bio”) has entered into agreements with a large multi-national corporation for a package transaction involving the Company's property located near Cambridge, UK.
Executive Moves at Roche contractpharma
December 12, 2018
Daniel O'Day, chief executive officer of Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of 31 December 2018.
Many Patients Withhold Information From Clinicians drugs
December 05, 2018
Many patients intentionally withhold information from clinicians, according to a study published online Nov. 30 in JAMA Network Open....
FDA Approves First Treatment for Rare Autoimmune Disorder contractpharma
November 30, 2018
Catalyst Pharmaceuticals, Inc. received approval from the FDA for Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection between nerves
Nkarta Appoints SVP & CMO contractpharma
November 28, 2018
Dr. Rajangam, who will be joining the company in December, is an experienced biotechnology executive with a track record of successfully developing cancer therapies.
Alvotech and Fuji Pharma Enter Biosimilars Tie-up contractpharma
November 27, 2018
Alvotech and Fuji Pharma are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.
Evotec AG, Immuneering in Discovery Alliance contractpharma
November 27, 2018
Evotec AG has entered into a research collaboration with Immuneering Corp., a data-driven drug discovery provider, to discover novel small molecules for rare hereditary metabolic diseases. Financial details were not disclosed.

Previous page 1 2 3 4 5 6 7 8 Next page